LENS EPITHELIUM AND HELIUM ION CATARACTOGENESIS

晶状体上皮和氦离子白内障发生

基本信息

项目摘要

Cataracts arise in uveal melanoma patients as a complication following their successful treatment with helium-ion radiotherapy. The objective of the proposed research is to determine the helium-ion-induced alterations in chromosomes and in protein expression that are important to cataractogenesis, and to develop strategies to diminish the incidence or severity of these changes. The current paradigm for cataractogenesis is focussed on genomic damage of lens epithelial cells leading to altered crystallin proteins. This proposal will examine two alternative mechanisms of cataractogenesis involving radiation-induction of basic Fibroblast Growth Factor (bFGF) in human lens epithelial (HLE) cells functioning either to alter the normal program of crystallin expression and thereby disrupting normal fiber formation, or the radiation-induced bFGF acting to hinder cell loss processes which leads to the formation of aberrant lens fiber formation. To this end experiments have been designed with three specific aims that will: Firstly, characterize acute and residual responses to helium-ion irradiation of cultured HLE cells grown on extracellular matrix. Quantitative dose-response measurements between helium-ion induced survival, repair capacity and yields of micronuclei, apoptotic nuclei, and persistent chromosomal rearrangements will be determined. Secondly, since radiation is known to induce bFGF in endothelial cells leading to inhibition of apoptosis, experiments are proposed that will determine whether helium-ion radiation changes levels of bFGF mRNA or protein in HLE cells, and whether there is a correlation with apoptotic events. Finally, an investigation of the possible modification of intracellular lens proteins by helium-ion radiation is proposed. The program will elucidate relationships between helium-ion- induced damage to the chromatin of HLE cells in vitro, and biological consequences to the cells surviving the resulting damage. In the revised application significant changes include: 1) an increased source of HLE cells, 2) new preliminary data from mRNA and protein analyses (SDS-PAGE) of exponential and confluent cell cultures, 3) new preliminary data with immunological evidence confirming feasibility to characterize lens cell differentiation, 4) some revised experimental protocols, and 5) and an updated review of literature published in this rapidly increasing area. This knowledge will allow correlative comparisons with available experimental work in vivo, and may provide a basis for potential changes to the treatment protocol that could reduce the risk of cataract. The biological mechanisms contributing to cataractogenesis may also be elucidated.
白内障是葡萄膜黑色素瘤患者的并发症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELEANOR A BLAKELY其他文献

ELEANOR A BLAKELY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELEANOR A BLAKELY', 18)}}的其他基金

NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer
NAPTA:优化临床试验设计
  • 批准号:
    9012031
  • 财政年份:
    2015
  • 资助金额:
    $ 29.55万
  • 项目类别:
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer
NAPTA:优化临床试验设计
  • 批准号:
    8812745
  • 财政年份:
    2015
  • 资助金额:
    $ 29.55万
  • 项目类别:
LENS EPITHELIUM AND HELIUM ION CATARACTOGENESIS
晶状体上皮和氦离子白内障发生
  • 批准号:
    2164817
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
LENS EPITHELIUM AND HELIUM ION CATARACTOGENESIS
晶状体上皮和氦离子白内障发生
  • 批准号:
    2711124
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
LENS EPITHELIUM AND HELIUM ION CATARACTOGENESIS
晶状体上皮和氦离子白内障发生
  • 批准号:
    2164818
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
CELLULAR AND MOLECULAR RADIOBIOLOGY
细胞和分子放射生物学
  • 批准号:
    3937813
  • 财政年份:
  • 资助金额:
    $ 29.55万
  • 项目类别:
CELLULAR AND MOLECULAR RADIOBIOLOGY
细胞和分子放射生物学
  • 批准号:
    3961681
  • 财政年份:
  • 资助金额:
    $ 29.55万
  • 项目类别:
CELLULAR AND MOLECULAR RADIOBIOLOGY
细胞和分子放射生物学
  • 批准号:
    3819740
  • 财政年份:
  • 资助金额:
    $ 29.55万
  • 项目类别:
CELLULAR AND MOLECULAR RADIOBIOLOGY
细胞和分子放射生物学
  • 批准号:
    3815834
  • 财政年份:
  • 资助金额:
    $ 29.55万
  • 项目类别:

相似海外基金

Temporal and spatial localization of TRAPP subunits during the cell cycle of HeLa cells
HeLa 细胞细胞周期中 TRAPP 亚基的时空定位
  • 批准号:
    432807-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
    University Undergraduate Student Research Awards
Analysis of the regulation of asymmetric cell division by using the artificially induced polarization of HeLa cells.
利用HeLa细胞的人工诱导极化分析不对称细胞分裂的调控。
  • 批准号:
    24657088
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The internalization mechanism of Ureaplasma parvum in HeLa cells.
小脲原体在 HeLa 细胞中的内化机制。
  • 批准号:
    23791241
  • 财政年份:
    2011
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco
宫颈癌 HeLa 细胞对人乳头瘤病毒 (HPV) E6 和 E7 基因沉默具有抗性的 MicroRNA 分析
  • 批准号:
    nhmrc : 519809
  • 财政年份:
    2008
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Early Career Fellowships
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
  • 批准号:
    3222-2002
  • 财政年份:
    2003
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
  • 批准号:
    3222-2002
  • 财政年份:
    2002
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
  • 批准号:
    3222-1998
  • 财政年份:
    2001
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
  • 批准号:
    3222-1998
  • 财政年份:
    2000
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
  • 批准号:
    3222-1998
  • 财政年份:
    1999
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
  • 批准号:
    3222-1998
  • 财政年份:
    1998
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了